Femtech startup Inne takes the wraps off a hormone tracker and $8.8M in funding
Post date: 2019-10-31 20:00:45
Views: 298
Berlin-based femtech startup Inne is coming out of stealth to announce an €8 million (~$8.8M) Series A and give the first glimpse of a hormone-tracking subscription product for fertility-tracking and natural contraception that’s slated for launch in Q1 next year. The Series A is led by led by Blossom Capital, with early Inne backer Monkfish
Please click Here to read the full story.
 
Other Top and Latest Questions:
2026 will bring more GLP-1 weight loss pills — and new habits. These stocks are poised to benefit
Student loan forgiveness is taxable again: Start planning for the 'tax bomb,' CFP says
New Year's resolutions rarely work, neuroscientist says: Here's a smarter way to build new habits
Retail investors close out one of their best years ever. How they beat Wall Street at its own game
Trump orders Chinese-controlled firm to unwind chip asset deal, citing national security risks
Chip stocks rally to start 2026 after third-straight winning year
China’s ‘Silicon Valley’ is building robots and fortune-telling AI apps at the same time
U.S. attacks Venezuela, captures Maduro and his wife; AG Bondi says charges include 'Narco-Terrorism'
'Queen City' Charlotte was the king of the stock market in 2025
Airlines restore Caribbean flights after U.S. lifts airspace restrictions tied to Venezuela strikes